Diagnostic News and Research

RSS

Blackstone to acquire leading life sciences investment firm, Clarus

Blackstone today announced that it has agreed to acquire Clarus, a leading global life sciences investment firm that has raised $2.6 billion since its founding. Clarus, with offices in the life sciences hubs of Boston and San Francisco, is focused on funding growth-stage investments, often in partnership with major biopharmaceutical companies through R&D collaborations.

5 Oct 2018

Expert proposes new model to generate automated updates of genetic test results

Maybe the genetic test report your doctor ordered says your DNA contains many “variants of unknown significance.” Currently, up to 70 percent of such reports are negative or inconclusive.

4 Oct 2018

Research seeks to revolutionize the way emergency services tackle CBRN incidents

Research led by Loughborough University seeks to set the new global 'Gold Standard' for how emergency services should tackle a chemical, biological, radioactive, or nuclear incident.

4 Oct 2018

RCIGM and IDbyDNA launch clinical trial to improve diagnostics for pediatric CNS infections

The Rady Children's Institute for Genomic Medicine and IDbyDNA, a metagenomics technology company translating microbial genomics into actionable information for healthcare providers, have launched a clinical trial to improve diagnostics for pediatric central nervous system infections.

3 Oct 2018

New method based on artificial intelligence may help predict epilepsy outcomes

Medical University of South Carolina neurologists have developed a new method based on artificial intelligence that may eventually help both patients and doctors weigh the pros and cons of using brain surgery to treat debilitating seizures caused by epilepsy.

3 Oct 2018

Beckman Coulter introduces Kaluza C software to improve clinical reporting

Beckman Coulter has launched the Kaluza C Flow Cytometry Analysis Software, an advanced data analysis system for the clinical laboratory.

From Beckman Coulter Life Sciences - Flow Cytometry 3 Oct 2018

ATS releases new guideline to help clinicians manage malignant pleural effusions

A new guideline to help clinicians manage malignant pleural effusions has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology.

3 Oct 2018

Penn scientists to explore new approach for predicting and treating diseases at individual level

A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.

3 Oct 2018

New diagnostic tool utilizes ultrasound to measure intracranial pressure post accidents

A new study confirms the efficacy of a new diagnostic tool that utilizes ultrasound to measure intracranial pressure following accidents. The technology will now be provided with artificial intelligence so that ambulance personnel can carry out examinations at accident scenes.

3 Oct 2018

Natural nanoscopic particles identified as possible diagnostic tool for Alzheimer's

Exosomes are natural nanoscopic particles released by most cell types, and are currently the focus of research because they represent a possible tool for the diagnosis of Alzheimer's. These particles are not so easy to isolate, and nanotechnology may help in this process.

3 Oct 2018

Feds settle huge whistleblower suit over Medicare Advantage fraud

One of the nation's largest dialysis providers will pay $270 million to settle a whistleblower's allegation that it helped Medicare Advantage insurance plans cheat the government for several years.

1 Oct 2018

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast cancer cells test negative for estrogen and progesterone receptors as well as HER2 receptors, genes that can play a role in the development of breast cancer.

1 Oct 2018

Researchers caution that expediting HLH treatment may miss underlying cancers

Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis report in a new study that extra care should be taken to ensure an HLH diagnosis doesn't obscure possible underlying cancers.

1 Oct 2018

Bowel Cancer UK and Royal College of Surgeons of Edinburgh launch fundraising appeal to enhance surgical research

Bowel Cancer UK, in partnership with the Royal College of Surgeons of Edinburgh, launch a £430,000 fundraising appeal for surgical bowel cancer research to establish Scotland’s first Colorectal Cancer Surgical Research Chair.

1 Oct 2018

Philips introduces Ingenia Ambition X 1.5T MR with fully-sealed BlueSeal magnet for helium-free operations

Royal Philips, a global leader in health technology, today launched the Ingenia Ambition X 1.5T MR. Incorporating Philips’ breakthrough BlueSeal fully-sealed magnet, the Ingenia Ambition X is the world’s first MR system to enable helium-free operations, reducing the chance of potentially lengthy and costly disruptions, and virtually eliminating dependency on a commodity with an unpredictable supply.

From Philips Healthcare 1 Oct 2018

HyFly research project aims to break chains of infection and prevent pandemics

Global air travel isn't restricted to people and goods - infectious agents, too, can make their way on board as unwelcome passengers and travel great distances within a matter of hours.

1 Oct 2018

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

The health care systems in some European countries lack the capacity to rapidly move a disease-modifying treatment for Alzheimer's disease from approval into widespread clinical use, which could leave 1 million people without access to transformative care if such a breakthrough occurs, according to a new RAND Corporation study.

1 Oct 2018

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.

30 Sep 2018

Scientists use machine learning to better predict learning difficulties in children

Scientists using machine learning - a type of artificial intelligence - with data from hundreds of children who struggle at school, identified clusters of learning difficulties which did not match the previous diagnosis the children had been given.

30 Sep 2018

Specially-designed wearable devices have potential to inform research into selective mutism

In a new study published in the journal Frontiers in Psychiatry, a team led by Child Mind Institute researchers found that specially-designed wearable devices that passively capture and quantify child vocalization features have the potential to inform research into selective mutism by providing standardized, objective measurements that can aid in diagnosis and assess the efficacy of treatment approaches.

29 Sep 2018

Diagnostic News and Research

Blackstone to acquire leading life sciences investment firm, Clarus

Expert proposes new model to generate automated updates of genetic test results

Research seeks to revolutionize the way emergency services tackle CBRN incidents

RCIGM and IDbyDNA launch clinical trial to improve diagnostics for pediatric CNS infections

New method based on artificial intelligence may help predict epilepsy outcomes

Beckman Coulter introduces Kaluza C software to improve clinical reporting

ATS releases new guideline to help clinicians manage malignant pleural effusions

Penn scientists to explore new approach for predicting and treating diseases at individual level

New diagnostic tool utilizes ultrasound to measure intracranial pressure post accidents

Natural nanoscopic particles identified as possible diagnostic tool for Alzheimer's

Feds settle huge whistleblower suit over Medicare Advantage fraud

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Researchers caution that expediting HLH treatment may miss underlying cancers

Bowel Cancer UK and Royal College of Surgeons of Edinburgh launch fundraising appeal to enhance surgical research

Philips introduces Ingenia Ambition X 1.5T MR with fully-sealed BlueSeal magnet for helium-free operations

HyFly research project aims to break chains of infection and prevent pandemics

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Scientists use machine learning to better predict learning difficulties in children

Specially-designed wearable devices have potential to inform research into selective mutism

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News